[Rapport de recherche]Le marché des services des organismes de recherche sous contrat (CRO) dans le domaine de la santé était évalué à 43 208,57 millions de dollars américains en 2019 et devrait atteindre 87 859,08 millions de dollars américains en 2027 ; il devrait croître à un TCAC de 9,5 % de 2020 à 2027. L'organisation de recherche sous contrat (CRO) fournit des services d'assistance aux sociétés pharmaceutiques, biotechnologiques et de dispositifs médicaux tout au long du développement du produit. Pharmaceutique& les entreprises de biotechnologie et l'industrie des dispositifs médicaux ont besoin de divers services de test tels que des services précliniques, des services de recherche clinique, des services de tests analytiques, des services de tests bio-analytiques et des services réglementaires. Les CRO sont spécifiquement conçues pour effectuer ces services de test afin de réduire les coûts et le temps internes des entreprises, nécessaires pour effectuer la vaste gamme de services de test pour se conformer aux normes réglementaires nationales et internationales. La croissance du marché mondial des services CRO de soins de santé est attribuée au nombre croissant d'essais cliniques et à l'augmentation des dépenses en R&D et en activités d'externalisation. Cependant, la pénurie de professionnels qualifiés est le principal facteur qui entrave la croissance du marché des services CRO de soins de santé
Couverture du rapport
Le marché mondial des services de recherche sous contrat (CRO) dans le domaine de la santé devrait connaître une croissance substantielle après la pandémie. Le COVID-19 a affecté les économies et les industries de divers pays en raison des fermetures, des interdictions de voyager et des fermetures d'entreprises. La crise du COVID-19 a surchargé les systèmes de santé publique dans de nombreux pays et a mis en évidence le besoin urgent d'investissements durables dans les systèmes de santé. À mesure que la pandémie de COVID-19 progresse, le secteur de la santé devrait connaître une baisse de croissance. Le segment des sciences de la vie prospère en raison de la demande accrue de produits de diagnostic in vitro et de l'augmentation des activités de recherche et développement dans le monde entier. Cependant, le segment des technologies médicales et de l'imagerie connaît une baisse de ses ventes en raison d'un plus petit nombre de chirurgies pratiquées et d'approvisionnements d'équipements retardés ou prolongés. De plus, les consultations virtuelles par des professionnels de la santé devraient devenir le modèle de prestation de soins courant après la pandémie. La télésanté transformant la prestation des soins, la santé numérique continuera de prospérer dans les années à venir. En outre, les essais cliniques perturbés et le retard qui en résulte dans les lancements de médicaments devraient également ouvrir la voie à des essais entièrement virtuels à l'avenir. De nouvelles technologies telles que l'ARNm devraient émerger et faire évoluer l'industrie pharmaceutique et le marché devrait également connaître une intégration plus verticale et des coentreprises dans les années à venir.
Régions lucratives pour le marché mondial des services CRO de soins de santé
Aperçu du marché
Augmentation du nombre d'essais cliniques pour stimuler la croissance du marché mondial des services de recherche sous contrat (CRO) dans le domaine de la santé
Les essais cliniques jouent un rôle déterminant dans l'approbation des médicaments et leur efficacité sur les maladies. Les études aident à comprendre les meilleures approches médicales dans certains domaines thérapeutiques. Les systèmes de santé à travers le monde observent une augmentation rapide du nombre d'essais cliniques. Des facteurs tels que la demande croissante de nouveaux médicaments et d'équipements médicaux, la prévalence croissante des maladies chroniques et la croissance des programmes de financement pour mener des essais cliniques sont responsables de l'augmentation du nombre d'essais cliniques à travers le monde.
En outre, de nombreuses entreprises se concentrent sur l'établissement de partenariats avec des organismes de recherche sous contrat pour mener des études cliniques de manière efficace. Par exemple, en décembre 2019, Cyclo Therapeutics a signé un accord de service avec Worldwide Clinical Trials, une organisation de recherche sous contrat pour exécuter les programmes cliniques des entreprises, pour l'évaluation de Trappsol Cyclo, un traitement de la maladie d'Alzheimer. De plus, en mai 2020, Daré; Bioscience, Inc. a conclu un partenariat stratégique avec Health Decisions, Inc., une importante organisation de recherche sous contrat, pour accélérer les études cliniques dans le cadre des programmes de santé des femmes. Un tel nombre croissant de collaborations augmentera éventuellement la contribution des organismes de recherche sous contrat dans l'exécution des études cliniques, ce qui stimulera à terme la croissance du marché.
Informations basées sur le type de service
En termes de type de service, le marché mondial des services des organisations de recherche sous contrat (CRO) en soins de santé est segmenté en développement de phase précoce, services de laboratoire, services de conseil et services de recherche clinique. En 2019, le segment des services de recherche clinique détenait la plus grande part du marché. En outre, on estime que le même segment enregistrera le TCAC le plus élevé au cours de la période de prévision.
Marché mondial des services CRO de soins de santé, par type de service - 2019 et 2027
Thérapeutique Indications basées sur les indications
En termes d'indication thérapeutique, le marché mondial des services des organisations de recherche sous contrat (CRO) en soins de santé est segmenté en oncologie, maladies infectieuses, troubles immunologiques, maladies respiratoires, maladies cardiovasculaires, troubles neurologiques et autres . En 2019, le segment des autres détenait la plus grande part de marché. Cependant, on estime que le segment de l'oncologie enregistre le TCAC le plus élevé au cours de la période de prévision.
Informations basées sur l'utilisateur final
En termes d'utilisateur final, les organisations mondiales de recherche sous contrat dans le domaine de la santé (CRO ) Le marché des services est segmenté en sociétés de dispositifs médicaux, sociétés pharmaceutiques et biopharmaceutiques, autres (instituts universitaires). Le segment des sociétés pharmaceutiques et biopharmaceutiques détenait la plus grande part du marché en 2019. De plus, le même segment devrait croître au TCAC le plus élevé au cours de la période de prévision.
Perspectives stratégiques
Les acteurs du marché mondial des services CRO de soins de santé adoptent les stratégies de lancement et d'expansion de produits pour répondre aux demandes changeantes des clients dans le monde entier, ce qui leur permet également de conserver leur marque à l'échelle mondiale.
Marché mondial des services CRO de soins de santé - par type de service
- Développement en phase précoce
- Études de découverte
- Chimie, fabrication et contrôle
- Services précliniques
- Services de laboratoire
- Tests bio-analytiques
- Tests analytiques
- Conseil Services
- Services de recherche clinique
- Phase I
- Phase II
- Phase III
- Phase IV
Marché mondial des services CRO de santé par indication thérapeutique
- Oncologie
- Maladies infectieuses
- Respiratoire Maladies
- Maladies cardiovasculaires
- Troubles neurologiques
- Autres
Marché mondial des services CRO de soins de santé par utilisateur final
- Entreprises de dispositifs médicaux
- Entreprises pharmaceutiques et biopharmaceutiques
- Autres (instituts universitaires)
Marché mondial des services CRO de soins de santé - par géographie< /h3>
- Amérique du Nord
- États-Unis
- Canada
- Mexique
- Europe
- France
- Allemagne
- Italie
- Royaume-Uni
- Espagne
- Reste de l'Europe< /li>
- Asie-Pacifique (APAC)
- Chine
- Inde
- Corée du Sud
- Japon
- Australie
- Reste de l'APAC
- Moyen-Orient et amp ; Afrique (MEA)
- Afrique du Sud
- Arabie saoudite
- EAU
- Reste de la MEA
- Amérique du Sud et Amérique centrale (SCAM)
- Brésil
- Argentine
- Reste de la SCAM
< /ul> Profils d'entreprise
- Charles River Laboratories, Inc.
- Iqvia Inc.
- Laboratory Corporation of America Holdings
- Parexel International Corporation
- Icon Plc
- PRA Health Sciences
- Syneos Health
- Medpace
- Wuxi Apptec
- PPD Inc.
- États-Unis
- Canada
- Mexique
- France
- Allemagne
- Italie
- Royaume-Uni
- Espagne
- Reste de l'Europe< /li>
- Chine
- Inde
- Corée du Sud
- Japon
- Australie
- Reste de l'APAC
- Afrique du Sud
- Arabie saoudite
- EAU
- Reste de la MEA
- Brésil
- Argentine
- Reste de la SCAM
< /ul>
Profils d'entreprise
- Charles River Laboratories, Inc.
- Iqvia Inc.
- Laboratory Corporation of America Holdings
- Parexel International Corporation
- Icon Plc
- PRA Health Sciences
- Syneos Health
- Medpace
- Wuxi Apptec
- PPD Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Factors like growing number of clinical trials and increasing expenditure in R&D and outsourcing activities are driving the growth of the market. In addition, rising biosimilars and biologics market are likely to have a positive impact on the growth of the market in the coming years.
The clinical trials cost a median of $41,117 per patient and $3,562 per patient visit. Clinical trial cost varies with the therapeutic area, phase of study and region where the clinical trial is being conducted.
Contract research organization (CRO) provides support services to the pharmaceutical, biotechnology, and medical device companies throughout the development of the product. Pharmaceutical& biotechnology companies and the medical device industry require various testing services such as preclinical services, clinical research services, analytical testing services, bio analytical testing services, and regulatory services. CROs are specifically designed to perform these testing services to reduce the in-house cost and time of the companies, required to conduct the extensive range of testing services to comply with the national and international regulatory standards..
The List of Companies - Healthcare Contract Research Organizations (CRO) Services Market
- Charles River Laboratories Inc.
- IQVIA Inc.
- Laboratory Corporation of America Holdings
- Parexel International Corporation
- Icon Plc.
- Pra Health Sciences
- Syneos Health
- Medpace
- Wuxi Apptec
- PPD Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jun 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jun 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jun 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)